A randomised, controlled, double blind, escalating dose study of alicaforsen enema in active ulcerative colitis

S.J.H. Van Deventer, J.A. Tami, M.K. Wedel, European Colitis Study Group

Gut (2004) 53: 1646-1651

View article

Bioavailability and therapeutic activity of alicaforsen administered as a rectal retention enema to subjects with active ulcerative colitis

P.B. Miner JR, R.S.Geary, J. Matson, E. Chuang, S. Xia, B.F. Baker & M.K. Wedel

Aliment Pharmacol Ther (2006) 23: 1427-1434

View article

Meta-analysis using individual patient data: efficacy and durability of topical alicaforsen for the treatment of active ulcerative colitis

S. Vegter, K. Tolley, T. Wilson Waterworth, H. Jones, S. Jones, D. Jewell

Aliment Pharmacol Ther (2013) 38(3): 284-293

View article

Disclaimer

The information in “published papers” is provided by Atlantic Healthcare plc, and while we endeavour to keep the information up to date and correct, we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability or availability with respect to the website or the information, products, services, or related graphics contained on the website for any purpose. Any reliance you place on such information is therefore strictly at your own risk.